- Clinical Trials
- April 2024
- 300 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- March 2024
- 159 Pages
From €7686EUR$7,950USD£6,602GBP
- Report
- May 2020
- 200 Pages
Global
From €6719EUR$6,950USD£5,771GBP
- Report
- January 2021
- 147 Pages
China, Global
From €3000EUR$3,324USD£2,667GBP
Metolazone is a type of cardiovascular drug used to treat hypertension and edema. It is a thiazide diuretic, meaning it works by increasing the amount of salt and water that is eliminated from the body through urine. This helps to reduce the amount of fluid in the body, which in turn helps to lower blood pressure. Metolazone is often used in combination with other drugs, such as ACE inhibitors or angiotensin receptor blockers, to provide more effective treatment. It is also sometimes used to treat congestive heart failure.
Metolazone is available in both generic and brand-name forms. Common brand names include Zaroxolyn, Mykrox, and Metozolv. It is available in tablet, capsule, and liquid forms.
Some companies that produce Metolazone include Mylan Pharmaceuticals, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more